Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the deals with the Trump administration on some drug prices versus others.
The White House nods to medication-assisted treatment and fentanyl test strips, despite recently placing new limits.
The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products.
The White House announced a drug pricing deal on April 23 with Regeneron, the final holdout among large pharmaceutical companies to sign most favored nation pricing deals with the Trump administration ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the first Trump Administration, though the portions of the order relating to the ...
Today, the White House Office of National Drug Control Policy (ONDCP) is announcing the release of the Trump Administration’s Drug Policy Priorities, a comprehensive and coordinated blueprint to ...
President Donald Trump is aiming to ramp up scrutiny on pharmaceutical ads — both on TV and social media — as his administration accuses companies of misleading the public about medications and their ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising medications, the Congressional Budget Office said on Friday. By Benjamin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results